ITEM VIEW

Legalising medical use of cannabis in South Africa : is the empirical evidence sufficient to support policy shifts in this direction?

dc.contributor.authorParry, C. D. H.en_ZA
dc.contributor.authorMyers, B. J.en_ZA
dc.date.accessioned2016-01-13T11:50:58Z
dc.date.available2016-01-13T11:50:58Z
dc.date.issued2014-06
dc.identifier.citationParry, C.D.H. & Myers, B.J. 2014. Legalising medical use of cannabis in South Africa: is the empirical evidence sufficient to support policy shifts in this direction? South African Medical Journal, 104(6):399-400, doi:10.7196/SAMJ.8135.en_ZA
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.otherdoi:10.7196/SAMJ.8135
dc.identifier.urihttp://hdl.handle.net/10019.1/98162
dc.descriptionCITATION: Parry, C.D.H. & Myers, B.J. 2014. Legalising medical use of cannabis in South Africa: is the empirical evidence sufficient to support policy shifts in this direction? South African Medical Journal, 104(6):399-400, doi:10.7196/SAMJ.8135.en_ZA
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractInkatha Freedom Party MP Mario Oriani-Ambrosini’s impassioned plea to legalise the medical use of cannabis must be understood in the context of his own condition as well as legislative changes in at least ten countries. This article argues that any decisions to shift policy must be based on a consideration of the evidence on the risks and benefits associated with the medical use of cannabis for the individual and broader society. It concludes that there are important gaps in the evidence base, particularly in human trials supporting the efficacy of cannabis use for treating and preventing medical conditions and alleviating negative symptoms associated with these conditions. South African researchers should be enabled actively to support development of the necessary evidence base actively by conducting preclinical and clinical research in this area. Human trials to establish the efficacy of the use of cannabis/cannabinoids in addressing AIDS wasting syndrome and other negative sequelae of HIV and AIDS are especially needed.en_ZA
dc.description.urihttp://www.samj.org.za/index.php/samj/article/view/8135
dc.format.extent2 pagesen_ZA
dc.language.isoen_ZAen_ZA
dc.publisherHealth & Medical Publishing Groupen_ZA
dc.subjectMedical cannabisen_ZA
dc.subjectCannabis -- Therapeutic use -- Law and legislation -- South Africaen_ZA
dc.titleLegalising medical use of cannabis in South Africa : is the empirical evidence sufficient to support policy shifts in this direction?en_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's versionen_ZA
dc.rights.holderSouth African Medical Journalen_ZA


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW